What does it mean if a person with advanced liver cancer stops talking

Silence in patients with advanced liver cancer means that they are unable to speak, which often indicates that the condition is worsening, such as the patient becoming extremely weak, having hepatic encephalopathy, lung metastasis or brain metastasis.

1. Extreme physical weakness: Generally, patients with advanced liver cancer may suffer from systemic organ failure due to the continued worsening of the disease, resulting in extreme physical weakness. At this time, the patients are unable to carry out normal activities, speak, eat and other basic actions.

2. Combined with hepatic encephalopathy: Hepatic encephalopathy is a dysfunction of the central nervous system based on metabolic disorders caused by liver dysfunction or portosystemic shunt. Patients with hepatic encephalopathy usually appear drowsy or comatose, so they may be unable to speak.

3. Lung metastasis: If patients with advanced liver cancer have lung metastasis, it may lead to increased bronchial secretions and bronchial spasm, and the phenomenon of inexpressibility may also occur at this time.

4. Brain metastasis: If brain metastasis occurs in the late stage of liver cancer, it may compress and affect the language center, causing sudden inability to speak and aphasia.

Liver cancer is a malignant tumor of the digestive system. It is highly malignant. Even for patients who have undergone surgery, the chance of recurrence is about 50% within 1-2 years. Due to the rapid progression of the disease, severe cases can be life-threatening. Patients should pay more attention to rest and avoid excessive fatigue. They can take medication according to the doctor's advice, such as diuretics such as hydrochlorothiazide tablets and furosemide injection, liver protection drugs such as magnesium isoglycyrrhizinate injection and reduced glutathione injection, antiviral drugs such as entecavir tablets, sofosbuvir velpatasvir tablets, targeted drugs such as sorafenib tosylate tablets and lenvatinib mesylate capsules, to relieve systemic discomfort. At the same time, radiotherapy, chemotherapy and other measures can be combined to prolong the patient's survival.